0001968582-24-000418.txt : 20240523 0001968582-24-000418.hdr.sgml : 20240523 20240523161757 ACCESSION NUMBER: 0001968582-24-000418 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 24978518 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Esposito Pamela CENTRAL INDEX KEY: 0001744425 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 18 COMMERCE WAY CITY: WOBURN STATE: MA ZIP: 01801 144 1 primary_doc.xml 144 0001744425 XXXXXXXX LIVE 0001737953 Replimune Group Inc. 001-38596 500 Unicorn Park Drive Suite 303 Woburn MA 01801 7812229600 Pamela Esposito Officer Common J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

79710 472680 61415105 05/23/2024 Nasdaq Common 05/23/2024 Stock Option Exercise Issuer N 45716 05/23/2024 Cash Common 05/15/2022 Rsetricted Stock Units Issuer N 5034 05/15/2022 NA Common 05/15/2023 Rsetricted Stock Units Issuer N 4960 05/15/2023 NA Common 12/23/2020 Exercised Stock Options ( ISO) Issuer N 24000 12/23/2020 Cash Y A portion of the sales under this filing are from Cashless Option Exercises that will occur within 3 months from the date of this filing. 05/23/2024 02/21/2024 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Pamela Esposito